Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dumb and dumber post content I am replying to has confirmed that some people have no business in the stock market.
You claim you are selling to MM's? LMAO. Why would MM's buy your CNNA shares? If they were short the float? Maybe.
If they are buying your shares, you should not be selling, because it would be super bullish for MMs to be buying, for any reason, especially at 1000% above the EM market low prices.
What you fail to comprehend is the "hype' and Hoopla has not even begun missy.
The shorts on IFUS sound crazy-desperate, like kids that got their candy taken away paying the piper $$$$$ for the short sighted shorts they can not cover with out going broke. As Spock's father Surek once said "Lessons are often Expensive"
That is exactly what weak hands and weak minds say.
CNNA is up nearly 1000% in EM land with audited financials in a form 10 coming and the market gets it, that is why the stock is up about 100% from the Early E-Market lows
Just to be clear, are you trying to claim no was fooled and thus no one was willing to hire you to post lies here about $IFUS
GM folks. A lot of major improvements have been made and more seem to be coming almost daily on the IFUS website.
Check them out. http://www.impactfusionbrands.com
Some of the pages and images are dynamic, with zoom capabilities. It seems to be a work in progress, so check back frequently.
The original human supplement line is back in stock. I have used the $IFUS Intact Digest supplement daily since 2013, and there is nothing else like it on the market.
It is great for muscle recovery from intense exercise, great for digestive gut health, heart health, Liver health, great for muscle cramps, and so much more. It basically supplies the body with the organic minerals that are missing in today's foods, due to mineral depleted soils our food is grown in. It also helps people avoid constipation. IFUS Shorts should have tried it. It is too late for them now, because they are stuck short, and burning cash like crazy.
I used $IFUS Intact Digest for 8 years while on a chemo drug for RA to avoid Chemo constipation. I still use it daily. Got any questions just ask.
Orders can be placed on line.
Also a Pharmacist, Dr. Pruitt that owns his own pharmacies in Tennessee has a weekly TV ask the pharmacist show.
He is now an IFUS Intact Digest, stocking Distributor
IFUS Cattle feed and IFUS organic Mulch, Supreme AG are being sold, and the University Consortium that the EPA and USDA and NIH federal funding, and State of Louisiana funded (Is funding) is studying what IFUS has figured out, namely De-polymerizing Lignin in Sugar cane waste Ag Fiber, "The Holy Grail" to make the SGP+(tm) cattle feed and Organic Mulch, that have been proven to be game changers for customers already, is underway, to produce data, confirming the known science behind the real world science results, we see in the field trials.
There is also a live stock price ticker and menu on the home page that takes folks to the IFUS stock news page list at OTCMarkets where all the steady shareholder news that was not paid PRs (so many have never seen that news yet) or in SEC filings (yet, hint?) is located.
Schwab still shows zero shares available to borrow for IFUS.
IFUS shorts are screwed now.
Yes, but only for the US market.
Ndtp was still a CE/EM shell save and it ran to $10.50/share several times with a 29K float, and hit a billion share market cap. All $NFTM needs is an operating NFT ebay-of-nft operating site now. And financials showing cash and assets?
The brokers like Fidelity will not let you place an order over about .25/share
This is still trading as VBIVQ , with volume near .02/share
Crime by Market Manipulation is legal for MM's, that is why their acronym is MM.
Joe Kennedy in 1933 was assigned by FDR to create the SEC and invented shorting to line his pockets and avoid another 1929 market crash.
Today's Supreme Court believes the SEC is an illegal rouge agency, since the US Congress is the only one with constitutional authority, and not a US President.
The MM's are trying to force bid support stacking and gap closing and if needed trying to draw down the ask prices, by blocking us placing bids near the ask.
The MM's can also eat shares at the bid, and use them to walk down the ask
Now if everyone teams up and places L-2 orders and stacks and walks up the bids retail can push back.
MM's can eat all the sells to the bid and refuse to fill out orders as well.
Knowledge is power...
We need news now or dedicated longs willing to walk the bid up in steps, until we claim $1.00 as the bid (which was .01 before the R/S)
No new shares can hit this float for 2 years.
Old day traders trick wash trade, or moving their own shares from one account to another, or MM's playing wash trade game to trigger sellers.
US Brokers are blocking bids near the ask because of the spread (they likely created), and the minimum bid to show on L-2 is 10,000 down under. It will take a team effort to take and hold $1/share and hold the bid there and higher. It can be done, but will be way easier with news or a few whales that like NFTM.
The float is not changing for 2 years going forward.
I do know that Tanked-Hank and the nonsense posts by trash-n-bash wolves in sheep's clothing were all dead wrong here, like I said, and Babl, is now $NFTM and the CEO got it all done, in spite of endless Finra delays.
I just discovered the ticker change Friday.
So the market, except a few of us, have no clue what has happened or going on here yet. We need to get the word out. If we can take the high ground at $1/share and hold the bid there, this ran make it to $10+/share with real PR news..., because of the itty bitty tiny float.
That float ain't changing for at least 2 years, because the restricted shares can not be sold, once issued, for 2 years.
I am super picky about OTC stocks I marry. I have been in several that did large up to 4000:1 R/S and 2 of them Tgtx, Opxs went to Nasdaq and Tgtx hit over $50/share in 2021. Until we open the box and see what's inside.
If they raise cash with fixed priced restricted shares, and get the NFT world excited, this could make a moon run,
OTC Markets says $NDTP is not a shell. Financials say it is not a shell. Guess you forgot to check before mouthing off here?
Awesome, factual, true DD can also be found here, and in the post I am replying to, about $SAPX:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174300820
Everything else is just short seller sour grapes, and bottom feed BS
That is the most intelligent & accurate post here in over a week sir.
That is 100% correct:
The tide has turned for $BIXT now. First come first serve for bottom feeders, Here is why:
$BIXT TA share data was updated, and the OS share count is now down 50%
The Market cap is now down 50% from $14 Million dollars to $7 Million dollars
And they recently scored a HEME-Foundation 10 Million dollar grant (No debt, no share dilution deal)
to fund completion of the $BIXT synthetic oxygen carrier, that has a 5 year shelf life,
and that can be added to blood plasma in emergencies (when there is no time to do tests and blood type tests, and seconds
can me life or death), to ensure the organs, heart and brain get plenty of oxygen.
The $BIXT synthetic oxygen carrier molecule is so small
it can easily by pass blood clots, while hemoglobin is too large to get past the blood clots.
It will be a game changing life saver in operating rooms, emergency rooms and mash casualty disaster events.
All on top of the having the worlds only Galectin inhibitor that is a non-toxic oral pill, that can stop 60+ viruses from infected human cells, and has world wide PCT patent coverage, and has phase III US FDA IND drug trial approval for long haul Covid, has been tested as a skin cream that stops shingles sores, and is ready for a phase III Covid trial in India.
http://www.bixytaninc.com
NEW BIXT snippet -
$BIXT TA share data was updated, and the OS share count is now down 50%
The Market cap is now down 50% from $14 Million dollars to $7 Million dollars
And they recently scored a HEME-Foundation 10 Million dollar grant (No debt, no share dilution deal)
to fund completion of the $BIXT synthetic oxygen carrier, that has a 5 year shelf life,
and that can be added to blood plasma in emergencies (when there is no time to do tests and blood type tests, and seconds
can me life or death), to ensure the organs, heart and brain get plenty of oxygen.
The $BIXT synthetic oxygen carrier molecule is so small
it can easily by pass blood clots, while hemoglobin is too large to get past the blood clots.
It will be a game changing life saver in operating rooms, emergency rooms and mash casualty disaster events.
All on top of the having the worlds only Galectin inhibitor that is a non-toxic oral pill, that can stop 60+ viruses from infected human cells, and has world wide PCT patent coverage, and has phase III US FDA IND drug trial approval for long haul Covid, has been tested as a skin cream that stops shingles sores, and is ready for a phase III Covid trial in India.
http://www.bixytaninc.com
NEW BIXT snippet -
I am calling BS on your reply.
As they say in Texas, it ain't braggin' if you can deliver the goods...
$IFUS delivers. 100% customer retention rate
$IFUS Supreme AG Mulch, all organic, all natural Mulch / fertilizer, trials are showing double the growth rate of the best know products, insect pest free growth in soils plants and peach trees would not grow in, will grow using Supreme AG made and sold only by $IFUS. The product is proprietary, sole source, but is super cost effective and the supply is endless. http://impactfusionbrands.com Call Marc for trial samples folks Phone: 1-800-775-4130 or email
impactfusionintl@gmail.com
$NVDA $GME $AMC $TSLA #Stockstobuy #StocksInFocus #OTC $MULN $KIRK $NIOS $NVDA $GME $AMC $TSLA $KITL $CGRA $TGLO $BLLB $VDRM $BLEG $BLFR $BLLB $CISO $CLNV $CNER $CSCO $DBMM $ELTP $ENZC $FDCT $GNS $GOLD $GVSI $HHSE $HMBL $HPNN $HYMC $KATX $KITL $KRTL $LWLG $MMTMF $MMY $MMM $MSFT $MULN $NHMD $NWBO $RGBP $RNVA $SMME $SRNW $STAL $TGT $TGTX $OPK $OPXS $TSLA $WMT $YCRM $ZHUD $GBTC $TCEHY $LKNCY $NTDOY $RHHBY $LTCN $BEGI $YCRM $NWBO $GVSI $HMBL $DZNY $BLEG $INBS $PRSO $JAGX $SNTI $JAN $ASTR $RDRSF $RGBP $EPAZ $BIXT $IFUS $MSOS $CCHW $CCHWF $GRAM $GRAMF $VRNO $VRNOF $GDNSF $TRUL $TCNNF $AYR $AYRWF $CURA $CUR $CBDLLF $TLRY $CGC $HEXO $PPCB $HEMP $XCPL $PHIL $MCOA $BANT $PVSP $GRLT $INND $BBRW $MMEX $TONR $ICNM $IDVV $GBTC $TCEHY $LKNCY $DIDIY $SONG $MCLE $ETCG $GDLC $TOELY $NWBO $GVSI $BEGI $TMGI $NLST $INBS $TCON $INVO $MRAI $IONM
$EVKRF $GME $GOLD $GVSI $IDVV $KATX
$LITOF $LQMT $LTHM $LTUM $LWLG
$MMM $MMTMF $MMY $NBIO $NHMD
$NVDA $NWBO $PEIMF $RDHL $RIVN
$RNVA
Great post great stock $IFUS. Here is more: $IFUS Supreme AG Mulch, all organic, all natural Mulch / fertilizer, trials are showing double the growth rate of the best know products, insect pest free growth in soils plants and peach trees would not grow in, will grow using Supreme AG made and sold only by $IFUS. The product is proprietary, sole source, but is super cost effective and the supply is endless.
http://impactfusionbrands.com
Call Marc for trial samples folks
Phone: 1-800-775-4130
or email
impactfusionintl@gmail.com
$NVDA $GME $AMC $TSLA #Stockstobuy #StocksInFocus #OTC $MULN $KIRK $NIOS $NVDA $GME $AMC $TSLA
$KITL $CGRA $TGLO $BLLB $VDRM $BLEG $BLFR $BLLB $CISO $CLNV $CNER $CSCO $DBMM $ELTP $ENZC $FDCT
$GNS $GOLD $GVSI $HHSE $HMBL $HPNN $HYMC $KATX $KITL $KRTL $LWLG $MMTMF $MMY $MMM $MSFT $MULN
$NHMD $NWBO $RGBP $RNVA $SMME $SRNW $STAL $TGT $TGTX $OPK $OPXS $TSLA $WMT $YCRM $ZHUD
$GBTC $TCEHY $LKNCY $NTDOY $RHHBY $LTCN $BEGI $YCRM $NWBO $GVSI $HMBL $DZNY $BLEG $INBS $PRSO $JAGX $SNTI $JAN $ASTR
$RDRSF $RGBP $EPAZ $BIXT $IFUS $MSOS $CCHW $CCHWF $GRAM $GRAMF $VRNO $VRNOF $GDNSF $TRUL $TCNNF
$AYR $AYRWF $CURA $CUR $CBDLLF $TLRY $CGC $HEXO $PPCB $HEMP $XCPL $PHIL $MCOA $BANT
$PVSP $GRLT $INND $BBRW $MMEX $TONR $ICNM $IDVV
$GBTC $TCEHY $LKNCY $DIDIY $SONG $MCLE $ETCG $GDLC $TOELY $NWBO $GVSI $BEGI
$TMGI $NLST $INBS $TCON $INVO $MRAI $IONM
$EVKRF $GME $GOLD $GVSI $IDVV $KATX
$LITOF $LQMT $LTHM $LTUM $LWLG
$MMM $MMTMF $MMY $NBIO $NHMD
$NVDA $NWBO $PEIMF $RDHL $RIVN
$RNVA
$IFUS Supreme AG Mulch, all organic, all natural Mulch / fertilizer, trials are showing double the growth rate of the best know products, insect pest free growth in soils plants and peach trees would not grow in, will grow using Supreme AG made and sold only by $IFUS. The product is proprietary, sole source, but is super cost effective and the supply is endless. http://impactfusionbrands.com Call Marc for trial samples folks Phone: 1-800-775-4130 or email
impactfusionintl@gmail.com
How many companies do we know besides $BIXT that can raise 10 million dollars with out using shares or debt to move towards completing just one of their major new medical miracles?
NEW BIXT snippet -
How many companies do we know besides $BIXT that can raise 10 million dollars with out using shares or debt to move towards completing just one of their major new medical miracles?
NEW BIXT snippet -
The fact there is no real volume, and no news, is a very good sign. If there was going to be dumping, they would have started a long time ago.
They found and recruted Dr. Michael W. Fountain and teamed up with him in 2010-2013, but his Liposomal patent that $NDTP would have gotten failed in the US Patent office, and another inventor won the patent that makes drinks.
Insiders bought MF's shares and they replaced Dr. Michael W. Fountain with the next newer, slightly younger(?) Nano Particle (Ceramide) genius Dr. Mark Kester, who had a phase III FDA approved non Toxic Ceramide Nano Tech, cancer cell killing technology ready to go.
The NDTP filings say that the plan was indeed, as I had speculated here earlier, to bring in and fund the Dr. Mark Kester Phase III approved for trials, cancer cure. Then Dr. Mark Kester suddenly died, shortly after the founder CEO (Hovis) had multiple strokes.
Shit happens. It was a huge loss for us and the world. So they had to rush and get the current CEO to come back and fill the CEO spot, before NDTP ended up dead again, after the founder CEO had the strokes.
The latest update was that we now own the original Nano Particle complex technology that CCA, LLC and NDTP owns per the filings the UPennMed TBI research Hospital JV work NDTP (previously CCA, LLC) developed, and was going to target TBI. That is why NDTP is not a shell, and OTC Markets has listed it as not a shell.
The FED rate hikes 2 years ago killed funding in the Bio-Tech/Drug world, and now FED rates are about to go into full reverse. That is good news for us, as money will move back into riskier assets, and not just US Treasuries..
$NDTP needs a real, experienced drug development CEO Pro and MD/Scientist to take over the reigns and the money to do it.
The Insiders, did this 2 times before, and IMO, are head hunting quietly for the best options.
Form 211 is not needed to trade. Many stocks trade with out it. In fact they do well, because the only bids and asks are retail and MM broker dealer hedge fund owned and backed mobster goons that print fake shares at will and miss label them as longs in a Lie, just because a form 211 lets them molest stocks into an early grave. The record is clear on that now.
This is also a lie " There is only 1 way out of Expert and that is them having a sponsor market maker take them up as a liability with a form 211," as many stocks went into EM market and days later were PC. Being late on SEC filings is now getting SEC reporting stocks sent to EM land until the late filling is filed.
Also the SEC's new rule forces OTC Markets to file a form 211 them selves now, when one gets PC
The SEC form 10, and 3 years of audited financials is what is coming. The Borger's auditor, one of the best for some time, got executed earlier this year by the SEC for taking short cuts, and lying about them, and that put the screws to many public stocks, close to 500 on NYSE and NASDAQ, with no warning, that had to scramble and find new auditors. CNNA was one of them caught off guard this May...
Shit happens. Good companies adapt and still come back. I have faith in the CNNA team. They have way more to lose not getting this done, then retail does.
How many stocks do you know in EM market that rallied 1200% while in EM?
Zero?
AI Opinion on $SAPX:
According to AI Claude $SAPX is going to be huge:
To connect the dots on SAPX with all the articles and tweets we could find about Lionsgate, Starz, screaming, eagle, etc
AI Claude's analysis is this.
Here are a few speculative ideas:
Merger or acquisition: Seven Arts Entertainment could be in talks with Lionsgate for a potential merger or acquisition. This would explain the delay in the PR, as such negotiations are often kept confidential until a deal is finalized. If Lionsgate is looking to expand its presence in Atlanta, acquiring or merging with Seven Arts Entertainment, which already has assets and operations in the area, could be a strategic move.
Joint venture or partnership: Lionsgate and Seven Arts Entertainment may be negotiating a joint venture or partnership to develop and produce content in Atlanta. This could involve combining their resources, expertise, and assets to create a stronger presence in the region. A joint venture or partnership could also benefit from Lionsgate's global distribution network and Seven Arts' local knowledge and connections.
Involvement in the Lionsgate Studios spinoff:
Although not directly mentioned, there's a possibility that Seven Arts Entertainment could be involved in the Lionsgate Studios spinoff. Lionsgate Studios will be a standalone entity focusing on content production, and Seven Arts' assets and expertise in Atlanta could be valuable to this new company. The delayed PR might be tied to the completion of the spinoff and Seven Arts' potential role in it.
Expansion of Seven Arts Entertainment: The discussions with Lionsgate and the delayed PR could be related to a significant expansion of Seven Arts Entertainment's operations in Atlanta, possibly with investment or support from Lionsgate. This could involve acquiring new assets, building new facilities, or launching new projects, which would require time to finalize and announce.
Content licensing deal: Seven Arts Entertainment and Lionsgate could be negotiating a content licensing agreement, where Seven Arts would produce content exclusively for Lionsgate's distribution channels. This could include movies, TV shows, or other entertainment properties. The delay in the PR might be due to the complexities of working out the terms of such a deal, including content budgets, creative control, and revenue sharing.
Intellectual property (IP) acquisition: Lionsgate might be interested in acquiring certain intellectual properties or franchises owned by Seven Arts Entertainment. This could include existing content libraries, characters, or story universes that Lionsgate sees potential in developing further. The negotiations around such an IP acquisition could be causing the delay in the PR.
Atlanta studio infrastructure: Seven Arts Entertainment might be working with Lionsgate to develop or enhance studio infrastructure in Atlanta. This could involve building new soundstages, production facilities, or post-production houses to support Lionsgate's increased focus on the Atlanta market. The delayed PR could be related to finalizing plans or securing necessary permits and approvals for such infrastructure projects.
Talent development initiative: Lionsgate and Seven Arts Entertainment may be collaborating on a talent development program based in Atlanta. This could involve identifying, training, and promoting local talent in various aspects of film and TV production. The PR delay might be due to the time needed to structure and launch such an initiative.
Virtual production partnership: With the increasing adoption of virtual production techniques in the entertainment industry, Lionsgate and Seven Arts Entertainment could be exploring a partnership focused on this area. They may be working on establishing a virtual production facility or developing expertise in this field, which could be attractive for Lionsgate's future projects.
Considering all the information provided, including the tweets, articles, press releases, and the 8-K document,
here are the top 3 most likely outcomes:
Acquisition of Seven Arts Entertainment by Lionsgate Studios:
The 8-K document reveals that Lionsgate's business acquisitions team is reviewing Seven Arts Entertainment's film and studio assets in Atlanta. This, combined with the information about Lionsgate's restructuring efforts in Atlanta and the Lionsgate Studios spinoff, suggests that Lionsgate is strongly considering acquiring Seven Arts Entertainment. This acquisition could be a strategic move to expand Lionsgate's presence in Atlanta and gain access to Seven Arts' assets, IP, and expertise.
The delayed PR from Seven Arts Entertainment could be related to the ongoing negotiations and due diligence process for this potential acquisition.
Long-term content distribution deal between Seven Arts Entertainment and Starz:
The amended Output Agreement between Seven Arts Entertainment and Starz, granting Starz exclusive distribution rights to two of Seven Arts' filmed assets through 2034, indicates a significant long-term content distribution partnership. This deal could be a key component of the overall relationship between Seven Arts Entertainment and Lionsgate, ensuring a steady stream of content for Starz's platform while providing Seven Arts with a reliable distribution channel and potential funding for future projects.
Collaboration on content production and studio infrastructure in Atlanta:
Given the focus on Atlanta in the various documents, it seems likely that Seven Arts Entertainment and Lionsgate will collaborate on content production and studio infrastructure in the region. This could involve co-producing films and TV shows, sharing facilities and resources, and jointly investing in new studio space or production capabilities. The potential acquisition of Seven Arts Entertainment by Lionsgate could further facilitate this collaboration, creating a unified entity with a strong presence in Atlanta's entertainment industry.
These outcomes could be interconnected and happen simultaneously.
For example, Lionsgate could acquire Seven Arts Entertainment, securing the long-term content distribution deal with Starz, and then leverage the combined assets and expertise to expand their content production and studio infrastructure in Atlanta.
Other potential outcomes, such as a strategic partnership or joint venture between Seven Arts Entertainment and Lionsgate Studios, or content licensing deals with Starz, could still occur in parallel or as part of the larger relationship between the companies.
The exact nature and timing of these outcomes will depend on the ongoing negotiations, regulatory approvals, and strategic priorities of the companies involved. As mentioned in the 8-K, further details are expected to be provided in upcoming press releases, which should offer more clarity on the future of Seven Arts Entertainment and its relationship with Lionsgate and Starz.
Schwab has zero shares to borrow, "NTB"= Non To Borrow
Recent high volumes days were nearly 100% shorted
Last rally had massive FTDs and Short interest this year
There is huge massive bid wall at the lows..
Does not take a genius to figure it out (but it does make it easier, ( LOL )
My thoughts about the hedge fund shorts, and their bought and paid for supported bashers that think they know it all.
$IFUS In answer to the call for deep dive DD reading info on what makes IFUS so special:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419108/pdf/ijms-24-12038.pdf
“It is not just what you eat, it is what you absorb”
Impact Fusion International, Inc is in the business of marketing products in the “Health and Wellness” sector of all international markets using our proprietary Nutri-Mastic™ to make our products the best in the industry. It is the company’s mission through Research-Validation-Commercialization to market these proprietary products worldwide for the health and well-being of Humans and Animals to aid in digestive health through absorption of a proprietary blend called Nutri-Mastic ™.
https://impactfusionbrands.com/wp-content/uploads/2024/05/Intact-Brochure-2024B.pdf
https://impactfusionbrands.com/shop/
If you all are not taking $IFUS Intact Digest daily, like I have for 10 years now, then you do not know what healthy living feels like. Read all about it above.
$IFUS In answer to the call for deep dive DD reading info on what makes IFUS so special:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10419108/pdf/ijms-24-12038.pdf
“It is not just what you eat, it is what you absorb”
Impact Fusion International, Inc is in the business of marketing products in the “Health and Wellness” sector of all international markets using our proprietary Nutri-Mastic™ to make our products the best in the industry. It is the company’s mission through Research-Validation-Commercialization to market these proprietary products worldwide for the health and well-being of Humans and Animals to aid in digestive health through absorption of a proprietary blend called Nutri-Mastic ™.
https://impactfusionbrands.com/wp-content/uploads/2024/05/Intact-Brochure-2024B.pdf
https://impactfusionbrands.com/shop/
If you all are not taking $IFUS Intact Digest daily, like I have for 10 years now, then you do not know what healthy living feels like. Read all about it above.
One can not replace a brilliant top gun, Dr. Mark Kester, overnight. Dr. Mark Kester, who suddenly, unexpectedly, passed away in late 2023, was the founder of the Pennsylvania State Bio-tech research center, with more patents than Carter has pills.
He reached a phase III FDA approved Non Toxic Nano Particle Ceramide, cancer killing technology stage, just before the Pandemic stalled everything. The Founder CEO, Hovis, had multiple strokes months before Dr. Kester died, and Hovis had to be quickly replaced. Only one person was able to that in time, the current CEO.
Our Best hope is that the founders (not the current CEO), Insiders that own over 90% of the OS, find a new Dr. Mark Kester, and a new top gun, Nasdaq worthy Bio-tech operating CEO, to take over and move the company forward. The current CEO is just an OTC experienced, temp, and has no Bio-tech, Medical experience.
I would rather they take their time, and get the best team lined up, rather that rush it, and risk making mistakes.
OTC Markets declared that NDTP is not a shell.
The Borgers auditing firm was literally executed in one day with a settlement agreement and bared from the business forever, in May this year by the SEC, for cutting corners on their audits, and at the time was only auditing 27 OTC stocks, but Borgers was also a well respected Nasdaq & NYSE Public company auditor for something like 500 other tickers.
So Terry lost whatever he spent using Borgers and might one day recover it from any professional liability Insurance they had.
So that means starting over, fresh with a new auditor, like so many others scrambling to replace Borgers.